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Abstract
Gabapentin, a drug used in the treatment of epileptic seizures and neuropathic pain, has shown 
efficacy in the treatment of alcohol dependence. Moreover, given that gabapentin is used in the 
general population (e.g., non-dependent individuals, social drinkers), we sought to utilize 
preclinical assessments to examine the effects of gabapentin on sensitivity to moderate alcohol 
doses and alcohol self-administration in rats with a history of moderate drinking. To this end, we 
assessed whether gabapentin (0, 10, 30, 120 mg/kg, IG) pretreatment alters sensitivity to 
experimenter- and self-administered alcohol, and whether gabapentin alone has alcohol-like 
discriminative stimulus effects in rats trained to discriminate a moderate alcohol dose (1 g/kg, IG) 
vs. water. Second, we assessed whether gabapentin (0, 10, 30, 60 mg/kg, IG) would alter alcohol 
self-administration in rats with a history of moderate alcohol consumption. Gabapentin 
pretreatment potentiated the interoceptive effects of both experimenter-administered and self-
administered alcohol in discrimination-trained rats. Additionally, the highest gabapentin doses 
tested (30 and 120 mg/kg) were found to have partial alcohol-like discriminative stimulus effects 
when administered alone (e.g., without alcohol). In the self-administration trained rats, gabapentin 
pretreatment (60 mg/kg) resulted in an escalation in alcohol self-administration. Given the 
importance of interoceptive drug cues in priming and maintaining self-administration, these data 
define a specific behavioral mechanism (i.e., potentiation of alcohol effects) by which gabapentin 
may increase alcohol self-administration in non-dependent populations.
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1.1 Introduction
Alcohol use disorders (AUDs) continue to be a significant health and societal burden. As 
such, there is continued interest in novel pharmacological treatment approaches for AUDs 
(Muller et al., 2014). Moreover, pharmacological compounds that are already FDA approved 
for other uses are especially attractive targets. To this end, there has been growing interest in 
gabapentin (Neurontin), a drug currently approved by the U.S. Food and Drug 
Administration (FDA) for the treatment of epileptic seizures and neuropathic pain. 
Gabapentin has been used for the treatment of alcohol withdrawal in alcoholics (Mirijello et 
al., 2015) and initial studies showed efficacy in the maintenance of abstinence and sleep 
disturbances in alcohol-dependent individuals (Furieri and Nakamura-Palacios, 2007, 
Brower et al., 2008, Karam-Hage and Brower, 2000, Anton et al., 2011). Furthermore, in a 
recent double-blind controlled randomized clinical trial gabapentin treatment resulted in 
increased rates of abstinence and number of no heavy drinking days, and had positive effects 
on craving, sleep, and mood (Mason et al., 2014).
Gabapentin is a GABA analog that is structurally similar to GABA, however, it does not 
bind to GABA receptors and does not affect GABA uptake or degradation (Taylor et al., 
1998, Sills, 2006). Gabapentin has been shown to bind with high affinity to α2δ-1 subunit of 
voltage-gated calcium channels (VGCCs; (Brown and Randall, 2005, Uchitel et al., 2010) 
and consequently gabapentin actions at presynaptic α2δ-1-containing VGCCs result in its 
ability to reduce postsynaptic excitability and decrease the release of excitatory 
neurotransmitters (Cunningham et al., 2004, Dooley et al., 2002, Fehrenbacher et al., 2003). 
Interestingly, gabapentin has a different electrophysiological and behavioral profile under 
alcohol-dependent and non-dependent conditions (Roberto et al., 2008), which emphasizes 
the relevance and importance of alcohol dependence-induced neuroadaptations on 
gabapentin efficacy. Additionally, this suggests that in non-dependent populations (e.g., 
social drinkers) gabapentin may have different behavioral consequences, which is important 
given that gabapentin is commonly prescribed. Accordingly, one of the goals of the present 
work was to examine the effects of gabapentin on sensitivity to moderate alcohol doses and 
alcohol self-administration in rats with a history of moderate alcohol drinking.
Interestingly, to date, characterization of the effects of gabapentin on the discriminative 
stimulus (i.e., interoceptive) effects of alcohol has not been reported. Such characterization 
is highly relevant given that the interoceptive drug cues can impact drug taking, seeking and 
relapse-like behaviors (Paulus and Stewart, 2014, Verdejo-Garcia et al., 2012, Wise et al., 
2008, Stolerman, 1992). Therefore, in male Long Evan rats trained to discriminate a 
moderate dose of alcohol (1 g/kg, IG) from water (IG) using well-characterized drug 
discrimination methods, the present study sought to determine whether gabapentin would 
alter the discriminative stimulus effects of alcohol, have alcohol-like effects, and whether 
sensitivity to the discriminative stimulus of self-administered alcohol would be altered.
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Additionally, surprisingly few preclinical studies have examined the effects of gabapentin on 
alcohol self-administration. In one study, gabapentin was found to reduce alcohol self-
administration in alcohol-dependent rats, with no effect in non-dependent control rats 
(Roberto et al., 2008). Pregabalin (Lyrica), a successor to gabapentin with a similar basic 
chemical structure and therapeutic profile, was found to reduce alcohol self-administration 
in alcohol-preferring Marchigian Sardinian (msP) rats (Stopponi et al., 2012). Therefore, in 
parallel to the discrimination studies, we sought to determine whether gabapentin would 
alter maintenance of ongoing alcohol self-administration, in male Long Evans rats with a 
history of moderate alcohol consumption. Based on the mechanism of action of gabapentin, 
we hypothesized that the compound would have alcohol-like effects and further, that self-
administration would be reduced by gabapentin pretreatment. Together, the goal of this 
experimental approach was that examination of the effects of gabapentin on the 
discriminative stimulus of alcohol may provide a behavioral mechanism to inform and 
expand our understanding of potential gabapentin-induced changes in alcohol self-
administration in rats with a history of moderate alcohol consumption.
1.2 Methods
1.2.1 Animals
Male Long Evans rats (Harlan Sprague–Dawley, Indianapolis, IN) were single 
(discrimination studies) or double (self-administration studies) housed in ventilated cages. 
Food intake was regulated to maintain body weight between 325 and 340 g for all the 
discrimination studies. Water was available ad libitum in the home cage. The colony room 
was maintained on a 12-h light/dark cycle, with lights on at 07:00. All experiments were 
conducted during the light cycle. Animals were under continuous care and monitoring by 
veterinary staff from the Division of Laboratory Animal Medicine (DLAM) at UNC-Chapel 
Hill. All procedures were conducted in accordance with the NIH Guide to Care and Use of 
Laboratory Animals and institutional guidelines. As described below, several strategies 
(within subject testing; used in multiple experiments) were taken throughout this work to 
reduce the number of animals needed for the conduct of the studies.
1.2.2 Behavioral Training Procedures
Alcohol discrimination training—Rats were trained to discriminate a moderate dose of 
alcohol (1 g/kg, IG) from water using a standard two-lever operant procedure as previously 
described (Randall et al., 2015, Besheer et al., 2014, Jaramillo et al., 2015). Briefly, alcohol 
(1 g/kg) or water was administered IG and immediately afterwards rats were placed in the 
chambers. Following a 10-min delay, both levers were introduced into the chamber and the 
house light was illuminated, signaling the start of a 15-min session. Training days varied on 
a double alternation schedule (alcohol, alcohol, water, water, …). During an alcohol session, 
completion of a fixed ratio 10 (FR10) on the alcohol-appropriate lever (e.g., right lever) 
resulted in the delivery of a sucrose reinforcer (10% w/v; 0.1 ml) and during a water session, 
completion of an FR10 on the water-appropriate lever (e.g., left lever) resulted in 
reinforcement delivery. The following accuracy criteria were met prior to testing: the 
percentage of appropriate lever responses before the first reinforcer, and during the entire 
session was >80% for at least 8 out of 10 consecutive days.
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Testing: Test sessions were similar to training sessions except that they were 2 minutes in 
duration (after the 10-min delay), and an FR10 on either lever resulted in sucrose delivery. 
Sucrose reinforcement was delivered to examine the effects of gabapentin treatment on 
overall response rates. For testing, cumulative dosing or single dose procedures were used as 
indicated in the Experiments. Cumulative alcohol dose testing procedures (Schechter, 1997) 
were similar to those we previously describe (Besheer et al., 2014, Besheer et al., 2012, 
Cannady et al., 2011). Briefly, to determine the alcohol curve (0.1, 0.3, 1.0, 1.7 g/kg, IG), 
rats initially received 0.1 g/kg alcohol and were placed in the chamber for the 10-min pre-
session delay and 2 min test session. At the conclusion of the session, the rats received a 
subsequent alcohol administration of 0.2 g/kg and another test session. This procedure was 
repeated with two subsequent administrations of 0.7 g/kg alcohol, which are additive to 
produce the stated dose range. Thus, testing of the alcohol dose curve was completed in ~48 
min. Test sessions were interspersed with training sessions and only occurred when 
performance during 3 out of 4 consecutive training sessions met accuracy criteria. No more 
than two test sessions were conducted per week.
Alcohol self-administration training—Rats were trained using the same two lever 
behavioral chambers and procedures as in previous studies from this laboratory (Randall et 
al., 2015, Besheer et al., 2013), with the exception that rats had an alcohol lever and an 
inactive lever. Locomotor activity was measured during the self-administration sessions by 
infrared photobeams that divided the behavioral chamber into 4 parallel zones. Self-
administration sessions (30 min) took place 5 days/week (M–F) with the alcohol lever on a 
fixed ratio 2 (FR2) schedule of reinforcement such that every second response on the lever 
resulted in delivery of alcohol (0.1 ml) into a liquid receptacle. Responses on the inactive 
lever were recorded, but produced no programmed consequences. A sucrose fading 
procedure was used in which alcohol was gradually added to a 10% (w/v) sucrose solution. 
The exact order of exposure was as follows: 10 % sucrose (w/v)/2 % (v/v) alcohol (10S/2A), 
10S/5A, 10S/10A, 5S/10A, 5S/15A, 2S/15A. There were two sessions at each concentration. 
Following sucrose fading, sweetened alcohol (2S/15A) continued as the reinforcer for the 
remainder of the study. Based on our previous findings using similar self-administration 
procedures, we typically observe moderate daily alcohol intake ranging from 0.5–0.8 g/kg 
(Randall et al., 2015, Besheer et al., 2013) and corresponding to approximately 40 mg/dl 
when blood alcohol concentration is measured immediately after the 30 min session 
(Besheer et al., 2013).
1.2.3 Experiments
Experiment 1. Effects of gabapentin on the discriminative stimulus effects of 
experimenter-administered alcohol—The goal of this experiment was to determine 
whether gabapentin would alter the discriminative stimulus effects of alcohol in 
discrimination-trained rats (n=6). All rats used in this experiment were also used in 
Experiment 2. Gabapentin (0, 10, 30, 120 mg/kg, IG) was administered 1 hour prior to the 
start of a cumulative alcohol dose response curve (0.1, 0.3, 1.0, 1.7 g/kg, IG). A repeated 
measures design was utilized such that each rat received each dose in a randomized order, 
with at least two training sessions between testing days.
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Experiment 2. Discriminative stimulus effects of gabapentin alone—To 
determine whether gabapentin has alcohol-like discriminative stimulus effects in 
discrimination-trained rats (n=6). Gabapentin (0, 10, 30, 120 mg/kg, IG) was administered 1 
hour prior to Water (1 g/kg, IG), after which rats were placed in the chambers for a test 
session. A repeated measures design was utilized such that each rat received each dose in a 
randomized order, with at least two training sessions between testing days.
Experiment 3. Effects of gabapentin on the discriminative stimulus effects of 
self-administered alcohol
Sweetened alcohol reinforcer: To determine whether gabapentin would alter the 
discriminative stimulus effects of self-administered alcohol, a discrimination/self-
administration (Discrim/SA) test session was conducted as detailed in (Besheer et al., 2012, 
Besheer et al., 2006). These test sessions differed in duration (30 min) and reinforcer 
(sweetened alcohol solution; 10%, w/v sucrose+10%, v/v alcohol) from the standard test 
sessions; however, as in the standard test session behavior was free to vary between the two 
levers since completion of an FR10 on either lever resulted in reinforcer presentation. 
Briefly, in these sessions, following water (IG) administration, rats begin the session 
responding predominantly on the water-appropriate lever; as the session continues and rats 
have consumed significant amounts of the sweetened alcohol reinforcer, responding shifts to 
the alcohol-appropriate lever, indicating that the interoceptive effects of the consumed 
alcohol are detected by the animal (i.e., behavior under discriminative stimulus control of 
alcohol). For testing, gabapentin (0, 10, 30, 120 mg/kg, IG; n=8) was administered 1 hour 
prior to the start of a Discrim/SA session. Water (IG) was administered prior to placement in 
the chambers. Some (n=5) of the rats used in Experiments 1 and 2 were also used in this 
experiment. A repeated measures design was utilized such that each rat received each dose 
in a randomized order, with at least two training sessions between testing days.
Sucrose reinforcer: To assess gabapentin effects alone under the same testing conditions, 
the same group of rats (n=8) was tested using the Discrim/SA procedure detailed above with 
the exception that the standard sucrose (10% w/v) reinforcer was used (i.e., no alcohol was 
added). Rats received gabapentin (0, 10, 30, 120 mg/kg, IG) 1 hour prior to the start the 
Discrim/SA test session. Water (IG) was administered prior to placement in the chambers. A 
repeated measures design was utilized such that each rat received each dose in a randomized 
order, with at least two training sessions between testing days.
Experiment 4. Effects of gabapentin on maintenance of alcohol self-
administration—Prior to initiation of testing, rats had 5 months of self-administration 
training. Baseline alcohol intake (mean±S.E.M. of 2 sessions prior to initiation of testing) 
was 0.83±0.04 g/kg. To assess the effects of gabapentin on the maintenance of alcohol self-
administration, on test days, rats received gabapentin (0, 10, 30, 60 mg/kg, IG; n=8) 1 h 
prior to a self-administration session. Doses were assigned in a repeated measures design 
with each rat receiving all treatments in a randomized order, with at least two baseline 
sessions between testing days.
Besheer et al. Page 5
Neuropharmacology. Author manuscript; available in PMC 2017 February 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
1.2.4 Drugs and Dosing
For the discrimination experiments, alcohol (95 %, w/v, Pharmaco-AAPER, Shelbyville, 
KY) was diluted in distilled water to a concentration of 20% (v/v) and administered IG, with 
volumes varied to obtain the desired dose. For the self-administration experiment, alcohol 
and sucrose were diluted with distilled water to the appropriate concentrations. Gabapentin 
was dissolved in distilled water and administered IG at a volume of 1 ml/kg with a 1 h 
pretreatment interval. Gabapentin dose ranges and pretreatment intervals were selected 
based on previous work (Filip et al., 2007, Roberto et al., 2008, McDonald et al., 2008) and 
pilot experiments. In pilot experiments 240 mg/kg gabapentin produced significant response 
rate reductions in discrimination-trained rats and as such, 120 mg/kg was the highest dose 
selected.
1.2.5 Data analysis
For the discrimination experiments (Experiments 1 and 2), response accuracy was expressed 
as the percentage of alcohol-appropriate responses upon delivery of the first reinforcer. For 
the Discrim/SA tests (Experiments 3), response accuracy was expressed as percentage of 
alcohol-appropriate lever presses across the session, and alcohol (g/kg) and sucrose (ml) 
intake was estimated from the number of delivered reinforcers. For all discrimination 
experiments, response rate (responses/min) was analyzed for the entire session and served as 
an index of motor activity. Complete expression of the discriminative stimulus effects of 
alcohol (i.e., full substitution) was defined as >80% choice of the alcohol lever upon 
completion of the first FR10 during test sessions. Partial substitution for the alcohol training 
dose was defined as >40% and <80% alcohol-appropriate responses (Glennon and Young, 
2011, Solinas et al., 2006). For the self-administration experiment (Experiment 4), alcohol 
intake (g/kg) was approximated based on body weight and number of reinforcements 
delivered. For all studies, one- or two-way repeated measures analysis of variance (RM 
ANOVA) were used to analyze data as appropriate. Post hoc analysis (Tukey) was used to 
determine differences between specific treatment conditions. Statistical significance was 
declared at P≤0.05.
1.3 Results
Experiment 1. Effects of gabapentin on the discriminative stimulus effects of 
experimenter-administered alcohol
Gabapentin pretreatment increased sensitivity to the discriminative stimulus effects of 
alcohol (Figure 1A), as confirmed by a two-way RM ANOVA that showed a significant 
gabapentin-induced potentiation of alcohol-appropriate responses [F(3,15]=3.44, p<0.04) 
with increased alcohol-appropriate responses following the highest gabapentin doses (30 and 
120 mg/kg). Partial substitution for the alcohol training dose was observed at the low alcohol 
doses (0.1 and 0.3 mg/kg) following the highest gabapentin dose (120 mg/kg), and at the 0.3 
mg/kg alcohol dose following 30 mg/kg gabapentin pretreatment. Additionally, confirming 
alcohol discriminative stimulus control, a dose-dependent increase in alcohol-appropriate 
responses was observed [F(3,15)=45.61, p <0.001]. No significant interaction was observed. 
Response rate was affected by gabapentin pretreatment as confirmed by a two-way RM 
ANOVA (Figure 1B). A significant main effect of gabapentin dose [F(3,15)=4.08, p<0.03], 
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alcohol dose [F(3,15)=5.11, p<0.01], and a significant interaction were observed 
[F(9,45)=2.71, p<0.01]. Gabapentin pretreatment (10 and 30 mg/kg) increased response 
rates at the lowest alcohol doses (0.1 and 0.3 g/kg), respectively relative to vehicle (p<0.02). 
Additionally, there was a trend for a response rate reduction at the highest alcohol dose (1.7 
g/kg) following pretreatment with the highest gabapentin dose (120 mg/kg; p<0.08). 
Together, these results show that gabapentin pretreatment potentiates the discriminative 
stimulus effects of low alcohol doses.
Experiment 2. Discriminative stimulus effects of gabapentin alone
Gabapentin administered alone did not have full alcohol-like discriminative stimulus effects, 
as alcohol-appropriate responses were below the substitution threshold (i.e., < 80% alcohol-
appropriate responses; Figure 2A). Additionally, the one-way RM ANOVA showed no 
significant gabapentin effects on alcohol-appropriate responses. However, partial 
substitution for the alcohol training dose was observed at the highest gabapentin dose (120 
mg/kg) as alcohol-appropriate responses were 44.7±19.2%. Responses rates were not 
significantly affected by gabapentin pretreatment (Figure 2B).
Experiment 3. Effects of gabapentin on the discriminative stimulus effects of self-
administered alcohol
Sweetened alcohol reinforcer—Addition of alcohol (10%, v/v) to the sucrose (10%, 
w/v) reinforcer resulted in an increase in alcohol-appropriate responding across the session, 
indicating that behavior was under discriminative stimulus control of the consumed alcohol. 
In the vehicle controls and the lowest gabapentin dose (10 mg/kg), almost full substitution 
for the alcohol training dose was observed 20 min into the session. In contrast, following the 
highest gabapentin doses (30 and 120 mg/kg) almost full substitution was observed 10 min 
into the session. This was confirmed by a significant main effect of time [F(2,14)=6.65, 
p<0.008], and a significant interaction [F(6,36)=2.61, p<0.03]. Gabapentin pretreatment (30 
and 120 mg/kg) significantly increased alcohol-appropriate responses during the first 10 min 
(p<0.05), indicating potentiated sensitivity to alcohol early in the session. Importantly, 
gabapentin pretreatment did not affect alcohol intake (g/kg; Figure 3B). Alcohol intake 
(g/kg) increased across time [F(2,14)=87.40, p<0.001]. Thus, the potentiation of the 
discriminative stimulus effects of alcohol within the first 10 min of the session following 
gabapentin pretreatment (Figure 3A), was directly related to increased sensitivity to the 
discriminative stimulus effects of the consumed alcohol and not to differences in the alcohol 
dose consumed. These findings support and extend the findings in Experiment 1 with 
experimenter-administered alcohol, to show that gabapentin pretreatment also potentiates 
sensitivity to the discriminative stimulus effects of consumed/self-administered alcohol.
Sucrose reinforcer—As shown in Figure 3C, following vehicle pretreatment alcohol-
appropriate responding remained low throughout the session given that sucrose (10% w/v) 
was the reinforcer (i.e., no alcohol was present in the solution). Interestingly, gabapentin 
pretreatment potentiated alcohol-appropriate responding (i.e., partial substitution) as 
confirmed by the two-way RM ANOVA showing a significant main effect of gabapentin 
dose [F(3,21)=4.87, p=0.01], with overall greater alcohol-appropriate responses at the two 
highest gabapentin doses (30 and 120 mg/kg; p<0.05). As shown in Figure 3D, sucrose 
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intake (ml) increased across the session [F(2,14)=510.63, p<0.001], with no significant main 
effect of gabapentin dose. These results are consistent with the findings of Experiment 1 
showing that in the absence of alcohol, gabapentin alone (specifically, 120 mg/kg) has some 
partial alcohol-like effects.
Experiment 4. Effects of gabapentin on maintenance of alcohol self-administration
Gabapentin pretreatment significantly increased alcohol self-administration (i.e., alcohol 
lever responses) as confirmed by a RM ANOVA [F(3,21)=3.74, p=0.03; Figure 4A], with 
significantly greater alcohol lever responses at the highest gabapentin dose (60 mg/kg) 
relative to vehicle (p<0.05). A corresponding increase in alcohol intake (g/kg) was also 
observed [F(3,21)=2.94, p=0.05; Figure 4C]. Analysis of cumulative alcohol responses 
across the session showed a significant main effect of gabapentin dose [F(3,42)=3.83, 
p<0.05, Figure 4B], with significantly greater alcohol lever responses at the highest 
gabapentin dose (60 mg/kg) compared to vehicle. A significant main effect of session time 
was also observed [F(2,42)=66.108, p < 0.001]. There was no significant interaction. 
Inactive lever responses were not affected by gabapentin pretreatment [mean ± S.E.M. 0: 1.0 
± 0.26; 10: 2.12 ± 0.85; 30: 1.0 ± 0.38; 60: 1.37 ± 0.53]. Interestingly, the increase in 
alcohol lever responses occurred despite a significant gabapentin-induced decrease in 
locomotor rate [F(3,21)=8.47, p<0.001, Figure 4D]. Post-hoc analysis showed that 
locomotor rate was decreased by all doses of gabapentin compared to vehicle (p<0.05).
1.4 Discussion
The goal of the present work was to characterize the effects of gabapentin on the 
discriminative stimulus effects of alcohol and alcohol self-administration. In rats trained to 
discriminate alcohol (1 g/kg) vs. water, gabapentin pretreatment potentiated the 
discriminative stimulus effects of low alcohol doses, in two separate assessments 
(experimenter- and self-administered alcohol, Experiments 1 and 3, respectively). Moreover, 
gabapentin was found to have partial alcohol-like effects when administered alone (e.g., 
without alcohol; Experiments 2 and 3). Interestingly, in separate rats with a history of 
alcohol self-administration, gabapentin pretreatment resulted in an escalation in alcohol self-
administration.
Gabapentin (30 and 120 mg/kg) administered prior to experimenter-administered alcohol 
potentiated sensitivity to low alcohol doses (0.1 and 0.3 g/kg, IG; Figure 1A), with rats 
showing partial substitution for the alcohol training dose (1 g/kg). Given that gabapentin 
(specifically 120 mg/kg) produced partial substitution when administered alone (in the 
absence of alcohol – Experiment 2), the gabapentin-induced potentiation of alcohol effects is 
likely driven by a pharmacological interaction between alcohol and gabapentin. Indeed, 
increased sensitivity to the effects of self-administered alcohol was observed following 
gabapentin pretreatment (30 and 120 mg/kg) when alcohol (10% v/v) was added to the 
standard sucrose reinforcer (Figure 3A). That is, by 10 min into the test session, at which 
point estimated alcohol intake for all treatment conditions was in the 1–1.5 g/kg range 
(Figure 3B), almost full substitution for the training dose was observed in rats pretreated 
with the highest gabapentin doses (30, 120 mg/kg). The advantage of this assessment is that 
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animals consume pharmacologically relevant levels of alcohol rapidly. In doing so, the 
interoceptive effects of the consumed alcohol drive a shift in lever selection, which is a 
strong demonstration of discriminative stimulus control and consistent with prior work 
(Besheer et al., 2006, Besheer et al., 2012, Hodge et al., 2001). Importantly, alcohol intake 
(directly estimated from response rate), did not differ between the gabapentin doses (Figure 
3B). Therefore, the gabapentin-induced potentiation of alcohol-appropriate responding was 
not due to a direct increase in the consumed dose of alcohol, which would, by definition, 
result in greater or more detectable interoceptive effects. Rather, gabapentin potentiated 
sensitivity to the interoceptive effects of the consumed alcohol. Interestingly, in the absence 
of alcohol in the reinforcer (i.e., sucrose reinforcer – Figure 3C), partial substitution for the 
alcohol training dose was observed at those same gabapentin doses (30 and 120 mg/kg). 
This data pattern lends further support to the premise that the partial alcohol-like effects of 
gabapentin contribute to the observed potentiation of sensitivity to alcohol when alcohol is 
administered (experimenter- or self-administered).
Interestingly, in Experiments 2 and 3 (both under sucrose reinforcer conditions), gabapentin 
(120 mg/kg) administered alone resulted in partial substitution for alcohol. Additionally, 
partial substitution for alcohol was also observed at 30 mg/kg gabapentin in Experiment 3 
(Figure 3C), but not Experiment 2 (Figure 2A). The difference in substitution patterns can 
likely be accounted for by the slightly different manner in which the dependent variables are 
generated across the two assessments. That is, during the standard substitution test (Figure 
2A), alcohol-appropriate responses are determined prior to delivery of the first reinforcer. In 
contrast, given the nature of the sweetened alcohol reinforcer assessment (Figure 3C) in 
which dynamic behavioral patterns are monitored to capture the change in the discriminative 
stimulus effects of the consumed alcohol, alcohol-appropriate responses reflect ongoing 
behavior throughout the entire session.
To our knowledge, the discriminative stimulus effects of gabapentin have not been 
previously characterized in regards to alcohol stimulus effects. The present findings of 
potentiation of low alcohol doses, suggest in part, some pharmacological overlap with 
alcohol. The therapeutic mechanism of action for gabapentin is likely through binding at the 
α2δ subunit of VGCC (Gee et al., 1996), which are present in L-type channels and can 
regulate presynaptic-release in brain N- and P/Q-type channels (Catterall et al., 2005, 
Dolphin, 2013). Functional studies have demonstrated gabapentin-induced inhibition of 
presynaptic VGCCs and attenuation of neurotransmitter release, including glutamate (Meder 
and Dooley, 2000, Dooley et al., 2002, van Hooft et al., 2002, Fink et al., 2000, Quintero et 
al., 2011). Therefore, it is not entirely surprising that gabapentin-induced CNS inhibition can 
potentiate alcohol-like effects and have partial alcohol-like effects alone. That is, even 
though the alcohol discriminative stimulus is a multi-component cue modulated by a variety 
of different receptor systems, pharmacological manipulations that, in general, promote 
neural inhibition or reduce neuronal excitation tend to have alcohol-like effects or can 
potentiate the discriminative stimulus effects of alcohol (Kostowski and Bienkowski, 1999, 
Grant, 1999). Interestingly, examination of the contribution of L-type VGCC to alcohol 
discriminative stimulus effects has found that antagonists of L-type VGCC tend not to have 
alcohol-like discriminative stimulus effects (De Beun et al., 1996, Green and Grant, 1999). 
However, they can modulate aspects of the discriminative stimulus effects of alcohol 
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(Colombo et al., 1994, Green and Grant, 1999, Green-Jordan and Grant, 2000) and this 
interaction can be related to the components of the alcohol cue (GABAA or NMDA 
receptors), and alcohol training doses (Green-Jordan and Grant, 2000). Together, the present 
work showing that gabapentin has alcohol-like effects and potentiates the alcohol-like effects 
of low alcohol doses, suggests that the α2δ subunit may play a role in modulating 
interoceptive sensitivity to alcohol.
In a study in a non-treatment seeking alcoholic population, gabapentin treatment did not 
change reports of subjective high or intoxication as assessed by the Subjective High 
Assessment Scale (SHAS) and Biphasic Alcohol Effects Scale (BAES) in a bar-lab setting 
(Myrick et al., 2007). The lack of an interaction between gabapentin on subjective sensitivity 
to alcohol is in contrast to the present findings in which gabapentin potentiated the 
interoceptive effects of low alcohol doses. Clearly it is difficult to directly compare the 
results from the bar-lab study to that of the present preclinical work; however, it is 
interesting to note that gabapentin label indications recommend avoiding or minimizing 
alcohol consumption while taking the drug due to potentiation of side effects such as 
sleepiness and dizziness. Such gabapentin-induced potentiation of alcohol effects is 
consistent with the results of the present discrimination assessments. Moreover, given the 
relevance of alcohol dependence-induced neuroadaptations to gabapentin efficacy (see later 
discussion), it is possible that an alcohol-dependent population may not show gabapentin-
potentiated sensitivity to alcohol relative to a non-dependent population. Indeed, in addition 
to a favorable safety profile, no drug substitution or gabapentin misuse was observed in the 
double-blind, randomized clinical trial in alcohol-dependent subjects (Mason et al., 2014).
Interestingly, in the present work gabapentin pretreatment (60 mg/kg) increased alcohol self-
administration, with parallel reductions in locomotor rate (Experiment 4; Figure 4A,B,D). 
While simultaneous measurement of locomotor activity within the self-administration 
context is advantagous, assessment of the effects of gabapentin on spontaneous locomotor 
behavior may be better evaluated in an open field. Indeed, prior work has shown no effects 
on open field locomotor behavior at similar or higher doses (Watson et al., 1997, Itzhak and 
Martin, 2000); but see (Munro et al., 2012). Moreover, the escalation in alcohol self-
administration was not entirely expected, as previous preclinical work showed no effect of 
systemic gabapentin pretreatment on alcohol self-administration in non-dependent animals 
(Roberto et al., 2008). However, it is interesting to note that intra-amygdala (central nucleus; 
CeA) gabapentin pretreatment induced a non-significant tendency for increased alcohol self-
administration in non-dependent rats, while reducing self-administration in alcohol-
dependent rats (Roberto et al., 2008). The authors relate this data pattern to be consistent 
with opposing electrophysiological effects of gabapentin in the CeA of non-dependent and 
dependent rats (i.e., increases in GABA current vs. decreases in ethanol-induced GABA 
current following gabapentin application, respectively). Therefore, it is possible that the self-
administration conditions of the present work were able to reveal a gabapentin-induced 
increase in self-administration following gabapentin pretreatment. Indeed, there are 
differences between that work and the present work (i.e., route of gabapentin administration; 
fixed ratio requirements; rat strains) that may account for the different findings. Indeed, 
further replication of the present findings will be important.
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One of the aims of the present work was to characterize the discriminative stimulus effects 
of gabapentin in parallel to the self-administration assessment in an effort to inform 
interpretation of any gabapentin-induced changes in drinking. A consideration to address is 
that the gabapentin dose (60 mg/kg) that increased alcohol self-administration was not 
specifically tested in the discrimination assessments. First, we were concerned that a high 
gabapentin dose (120 mg/kg) would result in a non-specific reduction in general locomotor 
activity in the self-administration trained rats. Second, given that 30 and 120 mg/kg 
gabapentin doses had similar effects in the discrimination studies, it is likely that a dose of 
60 mg/kg would also potentiate alcohol discriminative stimulus effects. Therefore, a possible 
behavioral mechanism underlying the increase in alcohol self-administration may be related 
to drug priming. For example, in self-administration models, a priming injection of the self-
administered drug or drugs with similar discriminative stimulus effects as the self-
administered drug can potentiate (i.e., prime) drug-seeking behavior (Anker and Carroll, 
2010, DiChiara and Reinhart, 1995, Fattore et al., 2003, Gerber and Stretch, 1975, de Wit 
and Stewart, 1981) and taking behavior (Norman et al., 1999, McKee et al., 2009, O’Malley 
et al., 2002, Brown et al., 2008). Such an explanation is supported by the discrimination 
assessments, in which gabapentin doses above 30 mg/kg had partial alcohol-like effects and 
potentiated the interoceptive effects of low alcohol doses. Therefore, gabapentin 
pretreatment may have served as a priming cue that contributed to initiation and subsequent 
enhancement of ongoing operant alcohol self-administration.
Together, the present work shows that gabapentin can potentiate the interoceptive effects of 
alcohol and increase alcohol self-administration. Given the importance of interoceptive drug 
cues in drug priming and maintaining self-administration, the current findings define a 
specific behavioral mechanism (i.e., potentiation of interoceptive alcohol effects) by which 
gabapentin may have the potential to increase alcohol drinking, specifically in non-
dependent populations (e.g., social drinkers). Increasing availability of treatment options for 
AUDs is essential and with a favorable safety profile and efficacy at maintaining abstinence 
and treating relapse-related symptoms in alcohol-dependent individuals (Mason et al., 2014) 
gabapentin may be a promising candidate. Given its widespread and current indicated usage 
in treating seizure disorders and neuropathic pain, the present work suggests that it may also 
be an important consideration to examine the emergence of maladaptive drinking patterns in 
social drinkers currently treated with gabapentin.
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Highlights
• Increased sensitivity to experimenter- and self-administered alcohol following 
gabapentin pretreatment
• Gabapentin pretreatment has partial alcohol-like effects
• Increased self-administration following gabapentin pretreatment
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Figure 1. 
Discriminative stimulus effects of alcohol following gabapentin pretreatment. Mean (±SEM) 
alcohol-appropriate responses (A) and response rate (B) following gabapentin pretreatment 
prior to testing a cumulative alcohol dose range (0.1 – 1.7 g/kg, IG) in rats trained to 
discriminate alcohol (1 g/kg, IG) vs. water (n=6). Partial substitution (>40% alcohol-
appropriate responses) for the alcohol training dose was observed at the low alcohol doses 
(0.1–0.3 g/kg, IG) following gabapentin pretreatment (120 mg/kg, IP), and at 0.3 g/kg 
following 30 mg/kg gabapentin pretreatment. Gabapentin pretreatment (10 and 30 mg/kg) 
increased response rates at the lowest alcohol doses (0.1 and 0.3 g/kg), respectively relative 
to vehicle (p<0.02). Shaded area (>80%) represents full expression of the discriminative 
stimulus effects of alcohol. *p<0.05 (30 mg/kg gabapentin vs. vehicle); +p<0.05 (120 mg/kg 
gabapentin vs. vehicle); #p<0.05 (10 mg/kg gabapentin vs. vehicle).
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Figure 2. 
Discriminative stimulus effects of gabapentin alone. Mean (±SEM) alcohol-appropriate 
responses (A) and response rate (B) following gabapentin administration in rats trained to 
discriminate alcohol (1 g/kg, IG) vs. water (n=6). Gabapentin alone did not have an overall 
effect on the discriminative stimulus effects of alcohol or response rate; however, partial 
substitution for the alcohol training dose was observed at the highest gabapentin dose (120 
mg/kg, IP). Shaded area (>80%) represents full expression of the discriminative stimulus 
effects of alcohol.
Besheer et al. Page 17
Neuropharmacology. Author manuscript; available in PMC 2017 February 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 3. 
Discriminative stimulus effects of self-administered alcohol following gabapentin 
pretreatment. Mean (±SEM) alcohol-appropriate responses (A) and cumulative alcohol 
intake (g/kg; B) in 10-min intervals for the sweetened alcohol (10% w/v sucrose/10% v/v 
alcohol) test session (i.e., sweetened alcohol reinforcer). Following pretreatment with the 
highest gabapentin doses (30 and 120 mg/kg, IP) a significant increase in alcohol-
appropriate responses was observed during the first 10 min, indicating potentiation of 
sensitivity to the discriminative stimulus effects of the consumed alcohol. Mean (±SEM) 
alcohol-appropriate responses (C) and cumulative sucrose intake (ml; D) in 10-min intervals 
for the sucrose (10% w/v) test session (i.e., sucrose reinforcer). Overall alcohol-appropriate 
responses were significantly increased following gabapentin pretreatment (30 and 120 
mg/kg, IP) indicating partial alcohol-like effects in the absence of alcohol. Rats were used in 
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both assessments and were trained to discriminate alcohol (1 g/kg, IG) vs. water (n=8). 
Shaded area (>80%) represents full expression of the discriminative stimulus effects of 
alcohol. *p<0.05 (30 mg/kg gabapentin vs. vehicle); +p<0.05 (120 mg/kg gabapentin vs. 
vehicle).
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Figure 4. 
Effects of gabapentin on alcohol self-administration. Mean (±SEM) alcohol lever responses 
(A), alcohol lever responses across the 30-min session (B), alcohol intake (g/kg; C), and 
locomotor rate (D) following gabapentin pretreatment (n=8). *p<0.05 different from vehicle. 
A significant increase in alcohol lever responses and alcohol intake (g/kg) was observed 
following gabapentin pretreatment (60 mg/kg, IG). The increase in alcohol lever responses 
was evident throughout the 30-min session. Locomotor rate during the self-administration 
sessions was significantly reduced at each gabapentin dose tested. *p<0.05 (vs. vehicle).
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